Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carley Turner

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
European Journal of Cardiovascular Nursing|March 27, 2021
Grounded theory: what makes a grounded theory study?Carley Turner, Felicity Astin
Hematological Oncology|August 10, 2022
A phase 1 study of ruxolitinib, steroids and lenalidomide for relapsed/refractory multiple myeloma patientsJames R Berenson, Clara Kim, Sean Bujarski, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 16, 2020
A Phase I Study of Ruxolitinib, Lenalidomide, and Steroids for Patients with Relapsed/Refractory Multiple MyelomaJames R Berenson, Jennifer To, Tanya M Spektor, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
European Journal of Cardiovascular Nursing|March 27, 2021
Grounded theory: what makes a grounded theory study?Carley Turner, Felicity Astin
Hematological Oncology|August 10, 2022
A phase 1 study of ruxolitinib, steroids and lenalidomide for relapsed/refractory multiple myeloma patientsJames R Berenson, Clara Kim, Sean Bujarski, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 16, 2020
A Phase I Study of Ruxolitinib, Lenalidomide, and Steroids for Patients with Relapsed/Refractory Multiple MyelomaJames R Berenson, Jennifer To, Tanya M Spektor, et al.
Pageof 1